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Abstract
Background: Cre/loxP-mediated genetic modification is the most widely used conditional genetic
approach used in the mouse. Engineered Cre and the mutated ligand-binding domain of estrogen
receptor fusion recombinase (CreERT) allow temporal control of Cre activity.
Results: In this study, we have generated two distinct transgenic mouse lines expressing CreERT,
which show 4-hydroxytamoxifen (4-OHT)-inducible and spontaneous (4-OHT-independent) Cre
activities, referred to Tg(BK5-CreERT)I and Tg(BK5-CreERT)S, respectively. The transgenic construct
is driven by the bovine Keratin 5 promoter, which is active in the basal epithelial lineage of stratified
and pseudo-stratified epithelium across multiple organs. Despite the difference in 4-OHT
dependency, the Tg(BK5-CreERT)I and Tg(BK5-CreERT)S mouse lines shared similar Cre-mediated
recombination among various organs, except for unique mammary epithelial Cre activity in Tg(BK5-
CreERT)S females.
Conclusion: These two new transgenic mouse lines for the analysis of basal epithelial function and
for the genetic modification have been created allowing the identification of these cell lineages and
analysis of their differentiation during embryogenesis, during perinatal development and in adult
mice.
Background
Gene targeting provides a powerful tool to address gene
function by the manipulation of the mouse genome
through homologous recombination in embryonic stem
(ES) cells (reviewed in [1]). However, germ-line genetic
modification often causes lethality or numerous effects
that interfere with the analysis of specific biological phe-
notypes. Conditional gene targeting using the Cre/loxP-
mediated recombination system (reviewed in [1,2]) offers
an alternative approach for the dissection of gene func-
tion. Cre recombinase expression can be regulated by tis-
sue or cell-type specific promoters in transgenic mouse
lines. Thus, Cre can recognize loxP sites to catalyze site-
specific recombination in a tissue/cell specific manner. In
Published: 8 January 2009
Journal of Biomedical Science 2009, 16:2 doi:10.1186/1423-0127-16-2
Received: 28 October 2008
Accepted: 8 January 2009
This article is available from: http://www.jbiomedsci.com/content/1/16/2
© 2009 Liang et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Journal of Biomedical Science 2009, 16:2 http://www.jbiomedsci.com/content/1/16/2
Page 2 of 8
(page number not for citation purposes)
addition to tissue/cell specific regulation of Cre expres-
sion, temporal control of Cre recombinase activity in
transgenic mice has been demonstrated utilizing Cre
recombinase fused with the mutated hormone-binding
domain of the estrogen receptor (ERT); this can be acti-
vated by the synthetic estrogen analog tamoxifen or 4-
OHT, but not by the physiological ligand 17-estradiol
[3,4]. Thus, such an inducible Cre recombinase transgenic
mouse model is able to further facilitate conditional gene
knockout analysis and allow the study of gene function at
specific time points in a highly controlled manner.
Keratin 5 (K5) is a member of type II keratins and
expresses with its type I keratin partner keratin 14 (K14)
in the basal layer of stratified squamous epithelium (SSC)
[5-7]. Utilizing K5 promoter-driven reporter gene expres-
sion in transgenic mice has been shown to recapitulate the
expression profiles of endogenous K5 in basal epithelia
[8,9]; these cells are thought to have enriched stem/pro-
genitor populations that give rise to the suprabasal differ-
entiated cells of stratified epithelia [8-12]. Generation of
transgenic mice expressing Cre recombinase driven by the
K5 promoter as well as by the K14 promoter have pro-
vided very useful genetic tools for the analysis of the basal
proliferating cells of SSC [13,14]. In addition, these
reports have demonstrated that K5-Cre and K14-Cre mice
exhibit Cre/loxP recombination activity through female
germ-line only, which potentially confines the breeding
strategy available for the analysis of tissue-specific gene
ablation, that is in generalized germ-line deleted strains
[13,14]. As an alternative, the K5 or K14 promoter
directed Cre fused with either a mutated version of ER or
PR (progesterone receptor) has allowed expression in a
variety of transgenic mouse lines, which offers ligand-
induced Cre/loxP-mediated recombination in utero or at
adult stage; these have proved to be powerful genetic
resources and have mostly concentrated on the analysis of
epidermal development and disease [15-19]. To
strengthen the genetic resources of the K5-derived epithe-
lial lineages, we have generated transgenic mouse lines
expressing the Cre recombinase fused with ERT driven by
the bovine K5 promoter on an inbred (C57BL/6J) back-
ground in this report.
Methods
Plasmid
The BK5-CreERT transgenic plasmid (Figure 1) was created
by multiple subcloning steps and is composed of an
excised 5.2-kb NotI-digested and NheI/Klenow filled-in
bovine K5 promoter followed by an 0.5-kb intron
sequence from the BK5-Cre plasmid (kindly provided by
Dr. Richard R. Behringer with an agreement of Dr. José L.
Jorcano), a 1.8-kb of EcoRI-digested/Klenow filled-in of
Cre-ERT  fusion gene derived from pCre-ER(T)  plasmid
(kindly provided by Dr. Richard R. Behringer with an
agreement of Dr. Pierre Chambon), a 0.5-kb SV40 polya-
denylation signal (pA) and 2 copies of the ~1.2-kb HS4
insulator sequence from the 5' region of the chicken -
globin locus (5' HS4; nucleotides 10~1199 from acces-
sion number U78775). This 5'-HS4 served as a barrier ele-
ment that protects genes from any chromosomal position
effect, which has been thought to result in histone modi-
fications via USF proteins [20,21]. The 10.8-kb NotI/SalI-
digested transgene was eluted and separated from the pBl-
uscript  vector backbone for pronuclear microinjection
[22].
Mice
The Tg(BK5-CreERT)I and Tg(BK5-CreERT)S mice bearing
the same transgene, BK5-CreERT (Figure 1) were generated
Organization of transgenic construct BK5-CreERT for the production of Tg(BK5-CreERT)S and Tg(BK5-CreERT)I mice Figure 1
Organization of transgenic construct BK5-CreERT for the production of Tg(BK5-CreERT)S and Tg(BK5-CreERT)I 
mice. IVS, intron; p(A), SV40 polyadenylation; 5' HS4, insulator derived from the 5' boundary of the DNaseI hypersensitive site 
of the chicken -globin locus.
BK5 promoter IVS
CreER
T
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1 kbJournal of Biomedical Science 2009, 16:2 http://www.jbiomedsci.com/content/1/16/2
Page 3 of 8
(page number not for citation purposes)
by pronuclear microinjection and further maintained on
a C57BL/6J background. ROSA26 Cre reporter mice
(Gt(ROSA)26Sortm1Sor; the Jackson Laboratory) on a
C57BL/6;129 mix background are referred to as R26R
mice in this report. The Tg(BK5-CreERT)I/+;R26R/+ and
Tg(BK5-CreERT)S/+;R26R/+ bigenic mice were generated
by crossing R26R/R26R females with Tg(BK5-CreERT)I/+
and Tg(BK5-CreERT)S/+ males, respectively. Occasionally,
the offspring of R26R/R26R males and Tg(BK5-CreERT)S/
+  females were generated and are referred to as
R26R;Tg(BK5-CreERT)S, as they are the progeny of
Tg(BK5-CreERT)S/+ females; these were used for the anal-
ysis of spontaneous Cre activity through the female germ-
line. The genotyping protocol for the R26R  allele was
according to the methodology for PCR genotyping pre-
sented on the web site of the Jackson Laboratory. Geno-
typing of the Tg(BK5-CreERT)I and Tg(BK5-CreERT)S mice
was determined by a 300-bp PCR product amplified by a
forward primer (5'-GGACATGTTCAGGGATCGCCAG-
GCG-3') and a reverse primer (5'-CGACGATGAAGCAT-
GTTTAGCTG-3'). The PCR conditions were 5 min at
94°C, 28 cycles for 1 min at 94°C, 1 min at 64°C, 1 min
at 72°C and a final 2 min extension at 72°C. All animals
were housed in microisolator cages (up to 5 mice per
cage) using specific pathogen free husbandry. All experi-
ments with mice were performed with the approval of the
Institutional Animal Care and Use Committee (IACUC) at
National Yang-Ming University.
4-OHT administration
4-hydroxytamoxifen (Sigma, St. Louis, MO, USA) was dis-
solved in dimethyl sulfoxide (DMSO; Sigma) at a concen-
tration of 25 mg/ml. The 4-OHT solution was emulsified
in sunflower seed oil (Sigma) by vortex followed by mix-
ing on a rotator for 4~6 hours. The mice were injected
intraperitoneally with three doses of 4-OHT (4~5 mg/kg
body weight) every other day.
Whole mount X-gal staining
The detailed experimental procedures had been described
previously [23]. After X-gal staining, the tissues were
embedded in paraffin and then were further processed to
give ~7 m thick sections. These tissue sections were
placed on slides, deparaffinied and then rehydrated,
which was followed by counterstaining with Nuclear Fast
Red (Muto Pure Chemicals CO., Tokyo, Japan) for 10
minutes. -galactosidase positive tissues were examined
by light microscopy (BX51, Olympus, Japan).
Results and discussion
Through pronuclear microinjection, four BK5-CreERT
transgenic founders were obtained. Each transgenic
founder was backcrossed to C57BL/6J for expansion of the
individual transgenic line. All transgenic founders were
fertile and transmitted BK5-CreERT  transgenes to their
progeny. To examine the Cre recombinase activity, BK5-
CreERT mice were bred with ROSA26 Cre Reporter (R26R)
mice [24] to generate Tg(BK5-CreERT);R26R bigenic mice;
this was followed by intraperitoneal 4-OHT injection.
Among these four transgenic mouse lines, three lines
exhibited 4-OHT induced Cre recombinase activity. We
selected an efficient and tightly controlled 4-OHT induci-
ble BK5-CreERT transgenic mouse line, referred to here as
Tg(BK5-CreERT)I, to be the representative line for further
study.
The 4-OHT inducible Cre activity of the Tg(BK5-
CreERT)I;R26R  bigenic mice was assessed in terms of
reporter (LacZ) gene expression (Figure 2). We found that
all K5 expressing tissues including the epidermis and its
derivatives (Figure 2b), the esophageal (Figure 2d) and
the foregastric mucosa (Figure 2f), the cervicovaginal epi-
thelia of the female reproductive tract (Figure 2h) as well
as the medullary thymic epithelium (mTECs; Figure 2j)
showed -galatosidase activity when analyzed by whole-
mount X-gal staining following histological sectioning. In
general, X-gal positively staining of the stratified and
pseudo-stratified epithelia across multiple organs was
noticed. Therefore, our results are complementary to pre-
vious reports that generated K5-CreERT and K5-CreERT2
transgenic mice and mainly concentrated on epidermal
Cre-mediated recombination [18,19].
Interestingly, one mouse line exhibited spontaneous Cre
recombinase activity in the absence of 4-OHT induction
and this line is referred to as Tg(BK5-CreERT)S. The
detailed mechanism that triggers this spontaneous Cre
activity remained unclear. X-gal stained tissues of Tg(BK5-
CreERT)S;R26R bigenic mice revealed that Cre activity ini-
tiated reporter LacZ gene expression started at around
embryonic day (E) 14.5 (Figure 3a). Histological sections
revealed that X-gal positive cells appeared in the epider-
mis, the whisker follicles, the hair follicles (Figure 3a), the
nasal cavity and the oral cavity (data not shown). At birth,
the esophagus and the forestomach, but not in the hind-
stomach (HS), also showed strong X-gal stained patterns
(Figure 3b). At this stage, the mTECs were expected to
exhibit -galactosidase activity because previous reports
showing that the thymic epithelial progenitors of devel-
oping thymus indicated expression by both K5 and K8 at
E12.5 [25], while adult mTECs expressed K5 specifically
[26]. However, the spontaneous -galactosidase activity in
the thymic epithelium of Tg(BK5-CreERT)S;R26R  mice
was undetectable at birth (Figure 3c) and was only
detected as showing a scattered pattern until postnatal day
(P) 7 (Figure 3d). Thus, our findings suggested that the
expression timing of CreERT in some organs, such as the
thymus, of Tg(BK5-CreERT)S  mice might not exactly
match that of endogenous K5 expression during organo-
genesis. Furthermore, in the urogenital system of theJournal of Biomedical Science 2009, 16:2 http://www.jbiomedsci.com/content/1/16/2
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Evaluation of 4OHT-induced Cre recombination in Tg(BK5-CreERT)I;R26R mice Figure 2
Evaluation of 4OHT-induced Cre recombination in Tg(BK5-CreERT)I;R26R mice. After 10 days of vehicle control 
(4OHT (-)) or 4OHT (+) treatment, the presence of -galactosidase activity in the skin (a & b), the esophagus (c & d), the 
stomach (e & f), the lower female reproductive tract (g & h) and the thymus (i & j) was examined by X-gal staining. Histological 
sections of the corresponding X-gal stained organs were counterstained by Nuclear Fast Red and it was then possible to detect 
positive X-gal stained epithelial cells (arrows). Non-specific -galactosidase activities were noticed in the hindstomach. FS, 
forestomach; HS, hindstomach; U, uterus; V, vagina; T, thymus; H, heart; M, thymic medulla; C, thymic cortex.
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Evaluation of spontaneous Cre recombination in Tg(BK5-CreERT)S;R26R mice Figure 3
Evaluation of spontaneous Cre recombination in Tg(BK5-CreERT)S;R26R mice. a: E14.5 embryos (left panel, R26R/+ 
(R26R) control; right panel, Tg(BK5-CreERT)S/+;R26R/+ abbreviated as K5-R26R) were stained for -galactosidase activity, which 
appeared in whisker and hair follicles of the K5-R26R embryo (arrows). b: Dissected stomach from newborn mice (P1) after 
whole mount X-gal staining revealed the presence of intensive blue-stained areas in the esophagus (E) and forestomach (FS; 
arrows) of K5-R26R mice. c & d: Dissected thymus from R26R or K5-R26R mice underwent whole mount X-gal staining and his-
tological section and this revealed scattering blue foci (arrows) in the K5-R26R thymic medulla (M) at P7 (d) but not at P1 (c). 
e: The urogenital system of R26R or K5-R26R females at P7 was dissected and stained for -galactiosidase activity. Histological 
sections of corresponding X-gal stained organs of a K5-R26R female are shown in the right panels. Arrows indicate positively 
stained epithelium; B, bladder; U, uterus; V, vagina; SV, sinus vagina; MV, Müllerian vagina; f & g: Histological sections of X-gal 
stained skin and trachea from adult offspring (R26R and R26R;Tg(BK5-CreERT)S) obtained by crossing a R26R/R26R male with a 
Tg(BK5-CreERT)S female. The -galactosidase activity showed tissue/cell-specific expression in the epidermal, hair follicle and 
sebaceous cells of the R26R;Tg(BK5-CreERT)S skin (arrows in f) and in the basal cells of R26R;Tg(BK5-CreERT)S trachea (arrows in 
g). Scale bars, 100 m.
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Tg(BK5-CreERT)S;R26R females at P7, the transitional epi-
thelia lining of the bladder and the stratified epithelia lin-
ing of sinus vagina (SV) markedly exhibited -
galactosidase activity, whereas very few X-gal positively
stained epithelial cells in the Müllerian vagina (MV) could
be detected (Figure 3e). The differential X-gal positive
staining in the MV compared to SV was possibly due to the
more advanced epithelial stratification of SV compared to
MV, which is initially lined by simple columnar epithelia
that resembles the uterine epithelia, and then transits to
stratified epithelia at perinatal stage [27,28].
Previously Hafner et al and Ramirez et al. independently
demonstrated that K5-Cre and K14-Cre express in female
oocytes and have suggested their applicability as female
germ-line deleter strains [13,14]. To determine whether
our  Tg(BK5-CreERT)S  transgenic mice exhibited female
germ-line Cre activity, we obtained offspring
(R26R;Tg(BK5-CreERT)S) from a cross of a R26R/R26R
male and a Tg(BK5-CreERT)S/+ female and analyzed spon-
taneous -galactiosidase expression compared to of con-
trol  R26R  mice. Our results showed that the X-gal
positively stained patterns remained specific to the K5-
expressing cell types as shown by examples of skin and tra-
chea (Figure 3f &3g). In the R26R;Tg(BK5-CreERT)S skin,
the -galactosidase activity showed tissue/lineage-specific
expression in the epidermal, hair follicles and sebaceous
cells (Figure 3f), suggesting that the stem cell populations
were targeted. In the R26R;Tg(BK5-CreERT)S  trachea,
intense X-gal-stained cells were found in the basal cells of
the pseudo-stratified epithelium (Figure 3g). Our data
suggested that the Tg(BK5-CreERT)S mouse line does not
behave as a female germ-line deleter as described in earlier
reports [13,14]. The spontaneous Cre activity of Tg(BK5-
CreERT)S mice enabled us to bypass the female germ-line
deletion effect and to use this line for Cre-mediate recom-
bination in a tissue-specific manner during embryonic
and early postnatal development.
Several organs such as mammary and prostate glands are
not typically considered to be stratified epithelium, but
these epithelial glands are composed of K5 expressing
basal epithelial cells and terminal differentiated luminal
epithelium. In our Tg(BK5-CreERT)S transgenic mice, but
not in our Tg(BK5-CreERT)I transgenic mice, Cre-medi-
ated recombination in the mammary gland was detected
and X-gal-stained cells were observed in both the luminal
epithelium and the basal epithelial cells of the mammary
glands at P7 (data not shown), in virgins (Figure 4b &4e)
and also during lactation (Figure 4c &4f). In addition,
prostate basal cells expressing K5 that showed -galactos-
idase activity were found in the basal compartment of the
Analysis of spontaneous Cre recombination in Tg(BK5-CreERT)S;R26R mammary glands Figure 4
Analysis of spontaneous Cre recombination in Tg(BK5-CreERT)S;R26R mammary glands. a-c: Whole mount X-gal 
staining of mammary fat pads; Arrows indicate ductal and alveolar structures that show X-gal positive staining in the K5-R26R 
mammary glands of virgin (b) and lactation (c) stage mice; this staining is not present in R26R mice (a). d-f: Histological sections 
of the corresponding X-gal stained mammary glands shown in a-c. Arrows indicated X-gal stained basal and luminal epithelial 
cells. a-c, cropped original magnification ×8; d-f original magnification ×200.
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Tg(BK5-CreERT)S;R26R anterior prostate (AP) lobes (Fig-
ure 5); however, this contrasted with the fact that expres-
sion was present in both the basal and the luminal
epithelium of the lateral prostate (LP) lobes (Figure 5).
These findings indicated that Cre activity can be present in
a subpopulation of epithelial glands and will enabled us
to define molecular and cellular mechanisms precisely
using these mouse lines within a subpopulation using lin-
eage tracing or conditional genetic experiments.
Taken together, we reported two new transgenic mouse
lines,  Tg(BK5-CreERT)S  and  Tg(BK5-CreERT)I, which
exhibit spontaneous and 4-OHT-inducible Cre activity
driven by a bovine K5 promoter, respectively. For analysis
of Cre/loxP-mediated recombination at the embryonic
and early postnatal stages using Tg(BK5-CreERT)S mouse
line, a breeding scheme that considers whether the male
or the female is carrying the BK5-CreERT transgene is not
necessary because there was no female germ-line Cre-
mediated recombination in our Tg(BK5-CreERT)S
females. The 4OHT-induced Tg(BK5-CreERT)I mouse line
will enable us to perform conditional genetics in tempo-
rally and spatially controlled manner.
Conclusion
These genetic resources generated in this study will not
only help us to understand the biology of the skin, but
will also support studies of the basal epithelial lineages of
pseudo-stratified, stratified and transitional epithelia as
they appear in the thymic medulla, the esophagus, the
Analysis of spontaneous Cre activity in Tg(BK5-CreERT)S;R26R prostate glands Figure 5
Analysis of spontaneous Cre activity in Tg(BK5-CreERT)S;R26R prostate glands. Histological sections of anterior and 
lateral prostate lobes (AP & LP) from control R26R/+ and Tg(BK5-CreERT)S;R26R (K5-R26R), which were counterstained by 
Nuclear Fast Red. The results revealed X-gal positively stained epithelial cells (arrows). Scale bars, 100 m.
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forestomach, the trachea, the bronchus, the bladder, the
cervicovagina, etc. Moreover, glandular organs such as
prostate glands, which are composed of K5-expressing
basal epithelium, can also be a target organ using these
new transgenic mouse lines; this will allow the genetic
fine-dissection of basal epithelial function in terms of epi-
thelial identity and differentiation.
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